Neuroone Medical Technologies (NMTC) Asset Writedowns and Impairment (2020 - 2025)
Neuroone Medical Technologies' (NMTC) quarterly Asset Writedowns and Impairment came in at $2500.0 in Q3 2025, down 81.63% on a QoQ basis from $13608.0 in Q3 2020.
Neuroone Medical Technologies (NMTC) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 2 years of Asset Writedowns and Impairment data on file, last reported at $2500.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,500.00 |
| Sep 30, 2025 | 2,500.00 |
| Sep 30, 2020 | 13,608.00 |
| Sep 30, 2020 | 13,608.00 |